Cefaclor Dry Syrup 125 mg/5 mL (Cefaclor Hydrate)
Cefaclor Hydrate 3.75g
Syrup · Prescription medication
Jeongwoo Pharmaceutical Co., Ltd.
MFDS item code 201900827 · Notified 2019.02.08 · Insurance code 694205231
Treatment of otitis media, respiratory infections (pneumonia, pharyngitis) and urinary tract infections (such as pyelonephritis)
This medication is effective against various bacteria including Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus, and Escherichia coli. It is used for respiratory infections such as otitis media, pneumonia, pharyngitis, tonsillitis, and bronchitis. It is also effective for urinary tract infections such as pyelonephritis, cystitis, and gonococcal urethritis. It can be used for skin infections such as boils, abscesses, folliculitis, soft tissue infections, infectious gangrene, and wound infections. It is widely used for the treatment of various infectious diseases and helps patients recover quickly.
As cefaclor, take 250 mg (potency) orally every 8 hours. In cases of severe infections (such as pneumonia) and infections with low susceptibility, the dosage can be doubled. For acute gonococcal urethritis, this drug should be given in a single dose along with 1 g of probenecid.
Administer 20 mg (potency) per kg of body weight orally every 8 hours. In cases of severe infections, otitis media, and infections with low susceptibility, a dosage of up to 40 mg (potency) per kg of body weight can be administered, with a maximum dose of
This drug is an antibiotic that kills bacteria by destroying the cell wall of certain bacteria. It should not be used in patients who have previously experienced severe allergic reactions or shock due to this medication. Patients who have had allergies to this drug or similar antibiotics should also avoid its use. Care must be taken when administering it to patients with allergies to penicillin-based antibiotics, those with asthma or a tendency to exhibit allergic symptoms such as skin rash, and patients with severely impaired kidney function. Patients who have difficulty with oral intake, elderly patients with poor nutritional status, and patients with gastrointestinal diseases should also be monitored closely. Rarely, serious allergic reactions such as shock and anaphylaxis can occur when using this medication, so symptoms should be carefully monitored. Serious skin reactions such as Stevens-Johnson syndrome, where severe rashes or blisters develop, can occur, so caution is warranted. Blood-related adverse reactions such as decreased blood cell counts may occur, necessitating regular monitoring. Rarely, liver dysfunction or kidney failure may develop, so liver and kidney function should be consistently monitored. Gastrointestinal symptoms such as diarrhea, abdominal pain, nausea, and vomiting may occur, with severe cases potentially leading to colitis; symptoms should be reported immediately. If unusual respiratory symptoms develop, treatment should be discontinued immediately and appropriate care sought. Central nervous system symptoms such as anxiety, insomnia, dizziness, and hallucinations can occur rarely. This medication can lead to dysbiosis, such as oral inflammation or candidiasis. Bleeding tendencies due to vitamin K deficiency or symptoms of vitamin B complex deficiency may appear, requiring caution. Interactions may occur when used with other medications, so it is essential to inform a doctor or pharmacist. Women who are pregnant or breastfeeding should be cautious with its use as safety may be compromised. It is advisable not to use this drug in infants younger than 1 month as its safety has not been established. Elderly patients may have an increased risk of adverse reactions due to declining body functions; thus, monitoring dosage and administration intervals is crucial. It is important to use this drug only for the minimum duration required for treatment to prevent the emergence of resistant organisms. This medication may influence urinalysis or blood test results, so inform medical professionals of its use during testing.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a special container that does not allow light to enter. Additionally, it is important to store it at room temperature, between 1 to 30 degrees Celsius, rather than in excessively hot or cold places. Proper storage will help maintain the drug's effectiveness over time.
Pink syrup powder
100 grams/150 mL
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Cefaclor Hydrate 3.75g
Syrup · Prescription medication
Jeongwoo Pharmaceutical Co., Ltd.

Cefaclor Hydrate 250mg
Hard capsule · Prescription medication
Ildong Pharmaceutical Co., Ltd.

Cefaclor Hydrate 250mg
Hard capsule · Prescription medication
Kolon Pharmaceutical Co., Ltd.
Cefaclor Hydrate 3.75g
Syrup · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Cefaclor Hydrate 250mg
Hard capsule · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Cefaclor Hydrate 250mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Cefaclor Hydrate 2.5g
Syrup · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Cefaclor Hydrate 3.75g
Syrup · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.